Study Information

What’s involved?

  • 3 days & nights inpatient stay
  • 9 quick follow-up appointments

Participants in this research are reimbursed $3,660 (& $500 for attending all visits) for their time and this clinical trial has been approved by an independent ethics committee.

About the study

This study is looking at a medication for the treatment for migraines, a form of headache which is normally experienced as a one-sided throbbing or pulsing head discomfort.  Migraines are one of the most prevalent neurological diseases for which medical treatment is sought and is a leading cause of disability for people under 50. This medication is designed to help prevent migraines from occurring.

How do I find out more?

If you have already registered with us but would like more information about this study, please call 1800 243 733 or schedule a call back. You can also email us at quoting “Migraine Prevention Study”.

If you are interested in participating and have not previously registered as a participant with us, fill in your details in the form below and we’ll be in touch soon!

  • 3
    Nights Inpatient Stay
  • 9
    Outpatient Visits

Minimum Eligibility Requirements:

  • Healthy Males & Females
  • Aged 18 - 55 years old
  • Body Mass Index (BMI) 18 - 30kg/m²
  • Weight 50kg - 100kg
  • No medical conditions
  • Not taking any prescription or over the counter medication